- Home
- SXTP vs SPHL Comparison
SXTP vs SPHL Comparison
Compare SXTP & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | SPHL |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.5M |
| IPO Year | 2023 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SXTP | SPHL |
|---|---|---|
| Price | $3.68 | $4.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.60 | N/A |
| AVG Volume (30 Days) | ★ 10.5M | 6.4M |
| Earning Date | 03-27-2026 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,364,945.00 | ★ $5,956,226.00 |
| Revenue This Year | $146.28 | N/A |
| Revenue Next Year | $24.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 202.10 | N/A |
| 52 Week Low | $1.36 | $1.92 |
| 52 Week High | $17.68 | $62.40 |
Technical Indicators
Market Signals| Indicator | SXTP | SPHL |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 48.25 |
| Support Level | $3.75 | $4.03 |
| Resistance Level | $4.19 | $4.74 |
| Average True Range (ATR) | 0.51 | 0.71 |
| MACD | -0.13 | -0.20 |
| Stochastic Oscillator | 30.20 | 11.84 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.